Company intelligence / Profile preview

Oculox Technologies

Muzzano, Ticino, Switzerlandoculox.com ↗

Ownership: Private
Development stage: Other

Overview

Oculox Technologies has demonstrated clinical efficacy and safety of its multi-mode laser system for intermediate age-related macular degeneration in published studies. The company is currently focused on regulatory validation to enable US market entry. Its implantable telemetry platform enables continuous intraocular pressure measurement, representing a significant advance over traditional methods.

Therapeutic areas: Ophthalmology
Modalities: DeviceLaser-based therapyImplantable micro-system (for intraocular pressure monitoring)
Industry: Therapeutic Medical Devices

Partnerships

Collaborations with eye clinics and specialists in the United States on clinical development of devices

Beyond the preview

Go deeper on Oculox Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oculox Technologies.

Explore the full profile